Biostem

Biostem

Created using Figma
Uiterst geavanceerde biochemische celtechnologie in combinatie met blockchain-technologie.

Biostem is een geavanceerde technologie die een revolutie teweeg wil brengen in de hedendaagse medische en biotechnologische industrie door een gedecentraliseerd platform te bieden dat kan worden gebruikt voor transactionele activiteiten, tracking-doeleinden, contractproductie en outsourcing, bewaking en registratie van patiëntgegevens, stroomlijning van levenscycli van medische apparaten en gezondheidszorg , contract manufacturing en Clinical trial management. Daarbij streven we er ook naar ervoor te zorgen dat moderne Biotech-producten voor iedereen beschikbaar zijn, niet alleen voor de rijkere, tegen lagere tarieven.
PRE SALE
1 apr. 2019
30 mei 2019
100% voltooid
Opgehaald geld - geen gegevens
past
Details token
Token Distributie
ICO Crowdfunding 30%
Founder Team 15%
Angel Funding 45%
Publisher 10%
Geaccepteerde valuta's
ETH
Bedrijfsgegevens
Geregistreerd land
Malaysia
aanvullende details
Categorieën
Platform, technologie

Over Biostem

MYK was established as a biotechnology manufacturer and Biotech Research Laboratory aiming to contribute to the world health and medical industry through globalizing biotechnology. Its main business areas are: health and medical industry, finance and industrial investment, and sophisticated technologies such as blockchain and Biotechnology. MYK regards technology as the core and quality as its life, and wholeheartedly builds the company into a world-class branded enterprise. Comprised of a world-class medical team and cutting-edge biotechnology equipment, MYK provides a global scaled advanced medical technology and research service platform. It provides world-class screening, diagnosis, treatment and rehabilitation services for oncological diseases; has built patient-centered, unique health management system; provide community-based prevention, diagnosis, treatment, rehabilitation, and health services, while also providing medical services. In addition, anti-aging services are supplemented to create a brand-new living experience; in response to the needs of an aging population and the improvement of the quality of life of residents, the company has created the “MYK Cell Bank” as an important carrier for healthy living and provides high-end international medical care. Health management, health care services and other age-based health care services should provide strength for the common people to achieve physical and mental health and a better life.

Biostem is a project by MYK aiming to revolutionize the traditional Medical and Biotechnology industry by providing a decentralized blockchain for storing patient, clinical and research record, and smart contracts like features for trustless outsourcing of Biotech contracts.

Our Mission

Biostem aims to contribute to the world health and medical industry by creating an ecosystem that would make the Patient’s Clinical Record and the Biotech Contract Outsourcing process, distributed through a decentralized blockchain, so that, anyone can have access to high end, state of the art medical diagnosis, treatment and Biotech products at ease.

Biostem

Biostem is state of the art ERC-20 Virtual Currency that allows peer to peer mode of payment and is deployed on decentralized ethereum blockchain based technology. The currency would be used for funding the research work, daily transactional activities happening within the Biostem health and financial ecosystem, for health care services and can also be used as a peer to peer exchange and store of value between users: securely, efficiently at reduced costs. Biostem will utilize ethereum blockchain technology to enhance its services to patients, hospitals, research centers and daily consumers, sellers, and merchants. This allows a level of transparency that was previously unrealized, while incentivizing users to adopt and use the platform. This will be done through the creation and use of Biostems.

Biostem Team

geverifieerd 0%

Aandacht. Het risico bestaat dat niet-geverifieerde leden feitelijk geen lid zijn van het team

Dr. Rubern
Chief Executive Officer
geverifieerde
Dawson Roland
Chief Technology Officer
geverifieerde
Kelson Beck
Chief Marketing Officer
geverifieerde
Matthew Hudson
Chief Financial Officer
geverifieerde
Catherine Harrison
Chief Operating Officer
geverifieerde
Rina
Biotech Consultant
geverifieerde
Allyson Brock
Human Resource Director
geverifieerde
Jozie Ayaz Khan
Business Development Director
geverifieerde
Brayden Parker
Biotech Research Consultant
geverifieerde
Sanjay Uttam Kharade
Business Consultant - Asia
geverifieerde

Biostem Laatste nieuws

  • Omdat er mogelijk tijdsverschillen zijn in informatie-updates, moet nauwkeurige informatie over elk ICO-project worden geverifieerd via de officiële website of andere communicatiekanalen.
  • Deze informatie is geen suggestie of advies over beleggen in ICO-financiering. Onderzoek de relevante informatie zelf grondig en besluit over ICO-deelname.
  • Als u denkt dat er problemen of problemen zijn die moeten worden gecorrigeerd voor deze inhoud, of als u uw eigen ICO-project wilt indienen dat wordt vermeld, e-mail ons.
Lees de disclaimer en risicowaarschuwing. Laat disclaimer en risicowaarschuwing zien.